Nexalin technology reports significant positive results of clinical study supporting the therapeutic benefits of its gen-2, 15 milliamp neurostimulation device on treatment-resistant depression

Results published in general psychiatry, a leading peer-reviewed journal results published in general psychiatry, a leading peer-reviewed journal

NXL Ratings Summary

NXL Quant Ranking